1 Arrested With Banned Drugs Worth Rs 5.22 Lakh From Valsad, Gujarat

Mira Bhayandar: Just under a month following the arrest of an individual caught with restricted drugs valued at Rs. 3.66 lakh in Kashimira, the Anti-Narcotics Cell (ANC) of the Mira Bhayandar-Vasai Virar (MBVV) police successfully traced the origin of the contraband to a commercial establishment situated in Valsad city, Gujarat, on Friday.

On September 18th, the ANC had apprehended a Mira Road resident found in possession of restricted drugs, including 300 bottles of cough syrup containing codeine phosphate and 10,800 tablets of Alprazolam. In the course of their investigations to determine the source of the contraband, the ANC managed to acquire a mobile number allegedly used by one of the suspects to communicate with buyers. Utilizing call data records and technical surveillance, the police located the accused’s phone to be active within the tower limits of Sethia Nagar in Valsad.

Promptly, ANC personnel led by PSI Santosh Ghadge rushed to Valsad and apprehended the accused. Subsequent intensive interrogations led the accused to disclose a larger consignment valued at over Rs. 5.22 lakh. This included 969 bottles of cough syrup containing codeine phosphate and 1,930 tablets of Alprazolam, both classified as scheduled drugs. The misuse and illegal sale of these drugs as narcotics are punishable under the provisions of the Narcotic Drugs and Psychotropic Substances (NDPS) Act of 1985.

Notably, stringent regulations govern the sale and purchase of such cough syrups, which are recognized as potent intoxicants. Nonetheless, numerous drug addicts consume these syrups to achieve a high. Moreover, unregistered suppliers allegedly distribute cough syrups and tablets to chemists who reportedly sell them at prices exceeding the maximum retail price, often without requiring the mandated prescription from a registered medical practitioner, according to sources.

Related Posts

  • Pharma
  • April 24, 2024
  • 44 views
Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

Kathmandu: In a bid to ensure the quality of medicines being prescribed to patients, the Department of Drug Administration (DDA) has been preparing to carry out on-site tests of medicines. For…

  • Pharma
  • April 23, 2024
  • 31 views
‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

Ranchi : Patanjali’s case is going on in the Supreme Court for misleading people by showing misleading advertisements. But there are many other pharmaceutical companies in this category. In fact,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

‘Auric’ Relied On Amazon Reviews For Research Claims To Cure Fatty Liver

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

Misleading Ads Case: Patanjali Issues Public Apology In A Daily Newspaper

AFMS Collaborates With IIT Delhi To Develop Medical Devices

AFMS Collaborates With IIT Delhi To Develop Medical Devices

Ayush Ministry Told To Act Against Firm Selling Medicine Named ‘Insulin’

Ayush Ministry Told To Act Against Firm Selling Medicine Named ‘Insulin’

2 Youths Arrested With 44770 Pregabalin Capsules

2 Youths Arrested With 44770 Pregabalin Capsules